Menu
X
image

Scientific Research: Medical Physics

MESSAGE FROM THE CHIEF

Medical physicists are highly-trained medical professionals who are uniquely positioned to drive clinic-wide improvements in quality and safety of radiation therapy and diagnostic imaging procedures. As a part of its commitment to high-quality cancer care in our community, the Cancer Center commits significant resources to its medical physics group.

Our team consists of 10 board-certified medical physicists who support the Center through clinical service, research, and education. Our objectives are to provide excellent clinical care, to conduct research that improves treatment outcomes of our patients, and to train the next generation of medical physicists.

Since 1980, the Center has collaborated with Louisiana State University (LSU) to operate a nationally-recognized graduate education program in medical physics. The program is the only one of its kind in Louisiana and only one of 40 accredited programs in the nation. In 2009, the Center established an accredited medical physics residency training program that has grown to become the largest in the nation. The educational programs – and institutional partnerships that have been forged therein – have created an academic environment that is truly unique in the community setting and carries tremendous benefits to our patients.

The Center’s medical physics program has attracted research funding from federal agencies and radiation oncology manufacturers that, in turn, make cutting-edge technologies and techniques available to our patients. Our research program emphasizes patient-oriented innovations that are routinely published in leading scientific journals. The physics team is professionally active and several serve on distinguished professional and scientific governing bodies. Lastly, our support of educational programs keeps us engaged in a continuous process of critical evaluation and self-improvement. These qualities result in a highly productive and dynamic medical physics group that is unparalleled in the Gulf South.

I encourage you to learn more about our program through our website and that of our academic partners at LSU.

Jonas D Fontenot, PhD

Chief of Physics

FACILITIES

TREATMENT DELIVERY SYSTEMS
  • 6 Elekta Infinity and 1 Versa HD radiotherapy accelerators with MLC and on-board imaging (6, 10, 15 MV x-ray and 7, 9, 10, 11, 13, 16, and 20 MeV electron beams) and volumetric modulated arc therapy.
  • 1 BrainLab Novalis stereotactic radiotherapy system
  • 1 TomoTherapy HI-ART II system
PATIENT DATA SYSTEMS
  • 1 GE Lightspeed RT CT Simulator (4D Advantage Windows)
  • 5 GE Discovery ST PET-CT
MOSAIQ ELECTRONIC HEALTH INFORMATION SYSTEM
TREATMENT PLANNING SYSTEMS
  • Philips ADAC Pinnacle systems (Clinical)
  • Raysearch Raystation systems (Research)
  • TomoTherapy planning station (Clinical)
  • TomoTherapy planning station (Research)
  • BrainLab stereotactic system (iPlan)
  • Mobius3D/MobiusFX treatment verification software (Research)
  • MU Check Software
BRACHYTHERAPY SYSTEMS
  • 2 Elekta Nucletron HDR Systems
  • MammoSite and SAVI (breast)
  • Varian VariSeed LDR planning system (prostate seeds)
  • Sr-90 ophthalmic applicator
  • I-125 eye plaques for ocular melanoma
DOSIMETRY LABORATORY AND EQUIPMENT
  • 3D beam scanning system (Welhoffer/Scanditronix)
  • 2D beam scanning systems (Scanditronix, TomoDose, CRS)
  • Anthropomorphic “Fred” torso phantom
  • Cylindrical water phantoms with 1D scanning
  • Rexon TLD in-vivo dosimetry system
  • Radiographic film scanning system (Vidar scanner, RIT, and TomoScan software)
  • Radiochromic film scanning system
  • Tissue equivalent phantoms (rectangular, cylindrical, and 4D)
  • Sun Nuclear (1D (Profiler) and 2D (MapCheck) diode arrays
PATIENT SUPPORT LABS/QA SYSTEMS
  • Treatment planning room
  • Block and mold room
LSU RESOURCES

All members of the academic physics group at MBPCC hold adjunct faculty appointments at LSU and are provided with full access to university resources, including:

The LSU university library

CAMD Synchrotron Radiation Facility: The 1.3 GeV electron storage ring (200 mA) has multiple beam lines of varying light energy. Two beam lines, produced by a superconducting wiggler magnet, allow medical radiological research using x-ray beams up to 40 keV.

Radiation Detector Development Lab: The Radiation Detector Development (RDD) Laboratory currently provides 480 sq. ft. of research space and is located in the renovated Nicholson Hall (which houses the Department of Physics and Astronomy); the lab occupies an additional 300 sq. ft. of lab space in the Nuclear Science building, which is rated for full use of radioactive materials. The RDD Lab has equipment and materials for design, fabrication, testing, and analysis of prototype detector systems. This includes: oscilloscopes; PC-based multi-channel analyzer; UNIX workstation for simulations, data processing and analysis; electronics prototyping equipment; dose calibrator; sealed long-lived radiation sources and collimation/shielding materials; general-purpose collection of nuclear instrumentation modular electronics; general-purpose collection of scintillation crystals and photomultiplier tubes (PMT); and imaging phantoms. Some project-specific items that are available include a light-tight (“black”) box, a selection of wavelength-shifting optical fibers (both individual fibers and assembled ribbons), three 5″x5″x1″ NaI(Tl) scintillation crystals, a multi-channel PMT, green-enhanced-response PMTs, custom-built detector assembly fixtures, and multi-channel DAQ cards.

Micro-CT Imaging System: Skyscan 1074 instrument with 37 μm resolution, 3 cm field of view and variable beam energy. Image reconstruction software has multiple capabilities and can run on a distributed computing environment.

Design and Construction Shops: The Department of Physics and Astronomy provides fully-staffed machine and electronics shops. These shops provide in-house fabrication facilities. In addition, a “student” machine shop is also available for faculty and student use. Other resources include a drafting shop operated by the College of Basic Sciences.

Animal Irradiation Facilities: The School of Veterinary Medicine supports radiological facilities for animals. Diagnostic facilities include x-ray fluoroscopy and CT scanning, and access to a PET/CT. MRI capability is anticipated in the near future. A small animal therapy facility includes a Varian Clinac 600C with a 52-leaf MLC and the Pinnacle treatment planning system.

Computing Facilities:

  • Various multi-teraflop systems, including Tezpur (15 Tflop, 360 node) and Pelican (3 Tflop, 32 node), operated by the Center for Computation and Technology
  • Linux cluster for student use, operated by Department of Physics and Astronomy.
  • The Medical Physics and Health Physics Program has several high-performance multi-processor Unix workstations for research and instructional purposes with the following software:
  • Philips ADAC Pinnacle3 research treatment planning system
  • TomoTherapy research treatment planning system
  • EGSnrc, MCNP (various versions), and GEANT Monte Carlo codes
  • A collection of deterministic neutron, photon and charge particle transport codes, including cross section processing routines
  • Fortran, C, C++ compilers with high-performance multi-threading extension
  • In-house software for advanced aerosol transport computations, external beam photon transport calculations, and brachytherapy seed identification and dosimetry.

Nuclear Science Building: The Nuclear Science Building serves primarily as a laboratory research and teaching facility. In addition, it gives housing to the LSU campus Radiation Safety Office. The building houses:

  • Six research laboratories equipped with fume hoods, sinks, counters, storage space. All are all acid-proof and are rated for radiochemistry, radiobiology, nano-sized aerosol, and generic radiation research. The aerosol laboratory houses a 1.8 x 1.5 x 0.6 m3 environmental chamber equipped with a real-time laser multi-channel aerosol spectrometer and nano-particle nebulizer. This lab supports experimental and computational study of how aerosols transport in confined spaces.
  • Multiple irradiation facilities (high-intensity radio-isotopic source irradiators having a maximum dose rate of 5000 R/min include): self-contained Co-60 irradiator, pool-type Co-60 irradiator, and Eberline Cs-137 calibrator/irradiator. Neutron facilities include: a subcritical assembly for neutron physics experiments and Cf-252 sources (total isotope mass of about 60 micro-grams) stored in two separate neutron irradiators (scalar thermal neutron flux of about 5 x 106 n/cm2/s).
  • Multiple radiation detection systems: HPGe detectors, NaI(Tl) detectors, a Si(Li) detector, liquid scintillation detector, etc. Counting laboratories maintain a cross-calibration schedule with the State of Louisiana Radiation Laboratory under the Louisiana Department of Environmental Quality, using NIST traceable standards.

GRADUATE TRAINING

We offer comprehensive training in the field of medical physics, including the Master of Science Degree, the Doctor of Philosophy Degree, post-doctoral research fellowships and clinical residency fellowships. The training program is jointly run by a partnership between Mary Bird Perkins Cancer Center and Louisiana State University. Degree programs are accredited and nationally recognized. The overarching objective of our training program is to provide outstanding opportunities for our trainees to prepare for successful careers in medical physics. Careers in medical physics may include patient care, research, education or a combination of these activities. The amount and type of training is typically tailored to best match the trainees’ career objectives. The table below lists the training programs that we recommend for several typical trainee objectives. The table is intended to serve as an initial guide for incoming trainees. Training requirements may vary depending on the individual trainee’s detailed objectives, performance, prevailing requirements on licensure and other factors.

Click here to see why one student chose our Medical Physics Program.

Click here for detailed descriptions of our graduate degree programs and sample curricula. 

For more information about postdoctoral training opportunities, click here to contact members of our faculty engaged in research.

Training Program

RESIDENCY TRAINING

Using a collaborative approach, Mary Bird Perkins formed a medical physics consortium with multiple affiliate sites, including Willis-Knighton Cancer Center in Shreveport, the University of Mississippi Medical Center in Jackson, MS and e+ Louisiana in Lafayette. This allowed for the expansion of residency training opportunities and resources. In conjunction with its affiliates, Mary Bird Perkins now has the largest radiation oncology physics residency training program in the United States.

For more information on our residency program, click the below items:

Program Overview

Program Objectives
The CAMPEP-accredited Mary Bird Perkins Cancer Center (MBPCC) Radiation Oncology Physics Residency Training Program provides training in clinical radiation oncology physics in preparation for American Board of Radiology (ABR) certification and independent practice in clinical medical physics in radiation oncology. The Program covers the majority of topics found in AAPM Report 90, “Essentials and Guidelines for Hospital-Based Medical Physics Residency Training Programs” through a combination of supervised training and independent work. After successful completion of the program, the resident will have covered the essential curricula for the board certification examination for radiation oncology physics. Residents are assigned to regular full-time clinical duties and are actively involved in patient care. Training specific to daily activities is divided into categories of dosimetry, brachytherapy, machine quality assurance (QA) and calibration, treatment planning and dose calculations, radiation safety, imaging, and special procedures (stereotactic radiosurgery, total skin electron treatment, etc.). Training also includes non-daily activities such as acceptance testing, commissioning, QA of various major clinic systems (linac, brachytherapy, treatment planning systems, etc.), and radiation safety/regulatory issues.

Program Consortium / Hub and Spoke Model 
MBPCC has reached agreements with three regional cancer centers to serve as partner programs in the residency program. These affiliate sites were chosen based on their interest in the program, and sufficient clinical staff and resources to effectively train residents. Partner locations include Willis-Knighton Cancer Center (Shreveport, LA) and the University of Mississippi Medical Center (Jackson, MS). These institutions and MBPCC represent a network of for-profit, non-profit, academic, community, and private entities. Each site has a local residency Program Director who is also a member of the Residency Program Committee.  This type of collaborative endeavor enables us to train additional residents, and provide access to more special procedures than are available at any one site.

Medical physicists and administration at all locations have shown a great deal of support in developing these partnerships.  The partner sites began resident training in July 2011, and currently each has two residents in the program. Details of the Programs at the Consortium Affiliate Sites may be found at:

Organizational Structure 
The Program is located within the Department of Physics, Radiation Oncology Services at MBPCC. The Program Director is Jonas Fontenot, Ph.D. and the Deputy Progra Director is Joseph P. Dugas, Ph. D. All components of the Program are administered by board certified or board eligible staff (medical physicists and medical dosimetrists) who report to the Chief of Clinical Physics at MBPCC.

The direction and content of the Program is governed by the Radiation Oncology Physics Residency Training Program Committee (Program Committee), which consists of the Program Director, Deputy Program Director, MBPCC Chief of Physics, a MDCB-certified medical dosimetrist, a radiation therapist, an ABR-certified radiation oncologist, and the program directors from each affiliate site.  The past MBPCC Chief of Physics serves on the Program Committee in an advisory capacity.  Program Committee members were chosen based upon their willingness to contribute to residency education and development of the Program. The Program Committee meets at least every three months.

Historical Development
MBPCC and its Physics department have been actively involved in Medical Physics education and training for over 25 years through the training of Medical Physics graduate students at Louisiana State University (LSU). In 2004, MBPCC entered into a formal agreement with LSU for an integrated academic-community cancer center model for Medical Physics. This agreement was integral in the 2006 CAMPEP accreditation of the M.S. in Medical Physics and Health Physics Program and the 2011 CAMPEP accreditation of the Ph.D. in Physics with specialization in Medical Physics within the LSU Department of Physics and Astronomy. Development of a CAMPEP-accredited Medical Physics Residency Program was a key step in LSU/MBPCC’s broader plan to provide comprehensive training in clinical medical physics.

In 2004, MBPCC administration granted approval for the creation of a Radiation Oncology Physics Residency Training Program. Over the next four years, departmental faculty and staff were added to a level adequate to establish and sustain the Program. Program development began in March 2009, under the supervision of Program Director Dr. John P. Gibbons, Jr.  The first resident began the Program on July 1, 2009 and completed residency training on August 31, 2011.

On May 1, 2010, Dr. Brent Parker was appointed Residency Program Director.  Dr. Parker continued to develop partnerships with affiliate sites and began preparing the program for CAMPEP-accreditation.  The second resident entered the Program on July 1, 2010.  In 2011, five new residents joined the program: one at MBPCC, and four at the affiliate sites.

On September 1, 2011, Dr. Gibbons again became Program Director, as Dr. Parker had taken another position.  Shortly thereafter, Dr. Gibbons promoted Kara Ferachi, M.S. to Deputy Director to handle the increased responsibilities associated with the program’s growth.  On October 13, 2011, application was submitted to CAMPEP for accreditation.  On August 16, 2012, the Consortium Program was granted full CAMPEP-accreditation through December 31, 2016. Dr. Joseph P. Dugas succeeded Ms. Ferachi as Deputy Program director in September 2012. In October 2014, Dr. Jonas Fontenot succeeded Dr. Gibbons as Program Director. There are currently nine residents in the program: five at MBPCC, and four at the affiliate sites.

Consortium Program Application Process

Beginning with the July 2015 admissions cycle, Mary Bird Perkins and all of our affiliate residency training sites are participating in the medical physics matching program (MedPhys Match Program) administered by National Matching Services, Inc.  Therefore, all interested applicants must register with the MedPhys Match Program (https://www.natmatch.com/medphys/appllanding.html). Since each affiliate of the Consortium has its own code in the MedPhys Match and will be independently selecting their next resident(s), applicants must indicate each individual affiliate to which they are applying to be considered for a position at that institution. Site codes for all Mary Bird Perkins Affiliates are as follows: Mary Bird Perkins Cancer Center, Baton Rouge, LA (Code: 12611), Willis-Knighton Cancer Center, Shreveport, LA (Code: 19311), and the University of Mississippi Medical Center, Jackson, MS (Code: 19411).  Applications will only be accepted through the AAPM CAP system and must include a cover letter, CV, graduate education transcripts, and three letters of reference.

The admissions process requires both the formal application through the AAPM CAP system and an interview. While each affiliate site in the Mary Bird Perkins Residency Consortium independently selects and interviews candidates, a general guideline to the process similar to that at the hub location (Mary Bird Perkins Cancer Center, Baton Rouge, LA) is followed by all affiliate sites. After the stated closing date for applications, application materials for all candidates will be reviewed by the Program and selected applicants scheduled for interviews. Each selected applicant will interview with the members of the Program Committee and/or faculty at each particular site. If all members of the committee are not available, the applicant will interview with at least a majority of the committee members or their designated substitutes.

Upon completion of the interviews, each interviewer provides an evaluation to the Program Director who will compile the information for each interviewee. The scores for each interviewee are presented to all the Program Committee members for discussion at the next scheduled Program Committee meeting. Ranking of applicants is done using the average scores from the interview evaluations with the lowest score being best. In the case where there is a tie, the final decision will be made by the medical physicist members of the Program Committee. Rankings will then be entered into the MedPhys Match.

Priority rankings will be given to M.S. and Ph.D. graduates of the LSU medical physics program and to postdoctoral fellows completing their respective programs at LSU and MBPCC.  However, as these applicants have historically been highly competitive for external residency positions, we anticipate that some of our positions may be filled with external candidates.  For positions beginning on July 1, all applications  are due in mid-December, with interviews taking place during January and February.  Offers will be made via the Med Phys Match in March.

Here is the schedule for the July 1, 2015 residency admissions:

  • December 15:  Deadline to submit application. Students to indicate which of the consortium programs they would like to apply for.
  • January – February:   Interviews for applicants at each location.
  • March 4-20:  Rank order list submitted to the National Matching Service (MedPhys Match).
  • March 27:  Match Results Released.
  • March 27 – April 26:  Program directors send letter of confirmation to match applicants. Applicants sign and return letters converting “match” to “placement.” List of unmatched applicants provided to MedPhys Match participating programs with unfilled positions.

Training Requirements

Clinical Rotations
Each resident is assigned to a clinical medical physics staff member to perform clinical tasks under his/her supervision. The MBPCC clinical structure consists of five clinical rotations with a medical physicist spending one month on a clinical assignment before rotating to the next assignment. In addition to these rotations, the resident will perform a month-long treatment planning rotation resulting in a resident rotation cycle of six months. This means that the resident will complete approximately four six-month cycles during the two-year residency.

This first cycle is designed to introduce the resident to the clinical duties for each rotation. In the first six-month rotation through the clinical assignments, the resident observes the clinical medical physicist performing the duties of that rotation. During this time they are expected to learn all clinical medical physics responsibilities for each rotation and document all clinical procedures.  They will also undergo formalized ethics and professionalism training during this time.  The resident has a limited hands-on role during the first cycle of rotations. All duties will be approved by the supervising clinical medical physicist.

The second cycle is designed for the resident to gain more hands-on experience in clinical assignments. The resident is expected to perform all clinical duties in the rotation under the supervision of a MBPCC clinical medical physicist. Most of the clinical assignments are performed by the resident and approved by the supervising clinical medical physicist.

After completion of the second cycle of rotations (i.e., end of first year of residency), the resident is credentialed by MBPCC to independently perform clinical medical physics assignments that do not require board certification. Resident credentialing will be approved by the Program Director and Chief of Clinical Physics.

In the second year of the residency, the resident is assigned to regular clinical duties within the Department of Physics. The resident independently performs those clinical duties for which they are credentialed. All duties that the resident is not allowed to independently perform (e.g., HDR treatment deliveries) continue to be done under the supervision of a clinical medical physicist. In these cases, appropriate documentation will continue to be approved by both the resident and supervising medical physicist.

Independent Projects
In parallel with the clinical assignments, the resident is assigned projects that cover topics not encountered in daily clinic duties (e.g., linac acceptance and commissioning, treatment planning system commissioning and beam modeling, etc.). These are designed to be major projects that require longer periods to complete (i.e., 1-2 months). These projects have specific goals and end points. They also require the resident to read and become familiar with appropriate materials (e.g., AAPM Task Group reports, journal articles, etc.) related to the topic of the project. These projects are designed to be completed outside of assigned clinical duties.

The resident is assigned to a mentor for the duration of each project. At the beginning of each project, the mentor provides the resident a written project description with the expected goals and objectives for the project. This description also includes a list of topical references which the resident is expected to read and understand. The mentor provides initial instruction related to the performance of the project (e.g., operation of equipment). The resident is expected to independently perform all tasks required to complete the project. Throughout the duration of the project, the mentor is available for questions and additional instruction or information as needed.

Upon completion of the project, the resident submits a written report documenting all tasks completed as required by the project mentor. The report includes appropriate documents and data specific to the project. Reports are expected to be of a quality appropriate for submission as a clinical release report at MBPCC.

Additional Duties
In addition to the clinical rotations and independent projects, the resident participates in any clinically-relevant major projects that may arise that are not specifically covered in the clinical and project assignments. These include, but are not limited to:

  • Acceptance testing and commissioning of new equipment
  • Testing and implementation of new treatment techniques
  • Implementation of new equipment and procedures
  • Clinically-related development projects
  • Evaluation of potentially new clinical technologies

Resident involvement in these additional projects will not detract from the clinical assignment and independent project requirements described above.

Second-year residents are involved in the training of first-year residents as allowed by clinical and project schedules. This role is intended to develop the resident supervisory skills within a clinical setting. The second-year resident does not formally oversee clinical duties assigned to the first-year resident, but assists in development of skills necessary for completion of projects assigned to the first-year resident (e.g., set-up and operation of scanning systems, operation of linear accelerators, IMRT QA, etc.).

Resident Evaluation
Residents are expected to pass regular oral exams as part of their performance evaluation. Each resident is examined over a two hour period every four months.  In addition to the oral exams, monthly feedback from the project and rotation mentors is used to determine satisfactory performance by the residents.

Tracking of resident time, tasks, clinical experiences, completed competencies, reports, and most evaluations is performed using the web-based Allied Health Student Tracking (AHST) software from Typhon Group (Metairie, LA). The Program Director or his designee is responsible for managing the software, including updating the curriculum as needed. Residents are able to access the system and enter information on their Program training requirements (completion of assigned competencies, attendance of required meetings, attended lectures, etc.). Program faculty have access to this data as well as many reporting tools to analyze and approve entries. An evaluation survey has been created for residents to evaluate the assigned faculty member for each month of clinical rotation or for each assigned project. Additionally, an evaluation survey has been created to allow faculty members to evaluate resident performance for each clinical rotation or project that the faculty member supervises.  A list of the Typhon Group competency groups, sample list of competencies for a competency group, and sample evaluation survey are shown in Appendix F.

If the resident’s performance on the mentor and instructor evaluations or oral exams is found to be unsatisfactory, the resident is counseled and a plan for additional study and evaluation of the particular topics is created. Failure to consistently perform at a satisfactory level in the clinical rotations or projects may result in dismissal from the Program and termination of employment.

At the end of the resident’s first year of training, the resident’s competency is evaluated for the possibility of independent clinical work without mentor oversight. The level of competency is based on the results of an examination occurring at the end of the first year. Satisfactory competency for independent work is determined by the Program Committee and must be approved by the Chief of Clinical Physics. Upon approval for independent work, the resident is credentialed to operate as a staff clinical medical physicist for all duties which a non-board certified medical physicist is able to perform. During this second year of independent clinical operation, the resident continues to perform independent project assignments on additional topics. The resident also continues to undergo regular oral examinations to monitor mastery of clinical topics.

In addition to the evaluations described above, the residents will sit for the annual RAPHEX examination in June of both years of residency. While not a formal part of the Program evaluation process, results of the RAPHEX exam are used as an objective evaluation of the resident’s knowledge relative to a national sample of the medical physics community.

Requirements for Program Completion
In order to satisfactorily complete the residency program, the resident must:

  1. If necessary, successfully complete any outstanding didactic coursework consistent with the AAPM report “The Essential Medical Physics Didactic Elements for Physicists Entering the Profession through an Alternative Pathway.” This coursework should encompass the following graduate-level core topics:
  • Radiological Physics and Dosimetry
  • Radiation Protection and Radiation Safety
  • Fundamentals of Imaging in Medicine
  • Radiobiology
  • Anatomy and Physiology
  • Radiation Therapy Physics

Outstanding didactic coursework will be provided by the CAMPEP-accredited LSU graduate program in Medical Physics. Didactic coursework will be completed in parallel with the clinical training requirements of the residency program. If the required didactic coursework exceeds one course/semester, the residency program duration may be extended to allow adequate time to fulfill the training requirements.

  1. Successfully complete all clinical rotations within the Department of Physics. Each resident will be assigned to a staff clinical medical physicist who will serve in a supervisory role for that clinical rotation.
  2. Successfully complete all independent projects which are assigned to cover major clinical medical physics topics not encountered on a routine basis (e.g., linac acceptance and commissioning, treatment planning system commissioning, etc.).
  • Attend various departmental meetings, conferences, and seminars that are relevant to the resident’s training. The resident shall have an attendance rate of no less than 75% for all meetings, conferences, and seminars.
  • Obtain satisfactory performance evaluations from staff medical physicists for all clinical rotations and independent projects. If evaluation is not satisfactory, complete additional assignments to make up any deficiencies.
  • Pass regular oral exams administered by supervising medical physicists, residency Program Director, and residency Deputy Program Director. If exam performance is not satisfactory, additional work in particular areas may be assigned followed by re-examination at a later date.

Physics Residents

Resident Salary and Benefits
Resident-related expenses include resident salary and benefits, training materials (online resources,books, journals, etc.), travel (car or airfare, room, board) for training or professional meetings, professional memberships, a laptop computer, and incidentals (such as office supplies).

Program residents are paid the same as physician residents in regional residencies of the LSU System for the first and second years of residency (PGY-1 and PGY-2), respectively. These salaries vary slightly by location, and in Baton Rouge, the stipends in 2013 are $44,168 (1st year) and $45,500 (2nd year).  Each resident is also provided benefits from the host institution, which may vary.  At MBPCC, benefits include medical, dental, life insurance, a 403(b) retirement account, and 15 days of paid time off with an additional 10 days of holidays and floating holidays.  Residents also receive up to $1,500 each year in reimbursement for residency-related educational and professional expenses, as described above.

Resident Activity
Each year a senior resident is selected from among the 2nd year residents.  The senior resident’s responsibility includes giving a resident report to the Program Committee on any issues or concerns with the Program. Additionally, the senior resident is primarily responsible for coordinating consortium-wide resident activity, such as periodic journal club, ABR Board review, and social events.

All residents and faculty are invited to attend workshops and/or symposiums hosted by MBPCC, and the annual residency graduation ceremonies in June.

Resident Application and Achievement Data.


Click image for full size view.

Program Resources

The following describes the Program resources available at MBPCC. Program resources at the affiliate sites may be obtained by contacting each Program director or on their website.

MBPCC is the only community-owned, independent, nonprofit cancer treatment, education, and research facility in Louisiana. MBPCC provides radiation oncology services in southeast Louisiana and annually treats approximately 2,000 new patients between its main center located in Baton Rouge, LA and four satellite facilities located within two hours of the main center. MBPCC currently has ten radiotherapy linacs and offers numerous brachytherapy and external beam procedures.

Faculty and Staff
MBPCC currently employs 13 medical physicists within its Department of Physics. Of these, five hold M.S. degrees, and eight hold Ph.D. degrees. At the present time, eleven of these medical physicists are certified by the American Board of Radiology (ABR) in Therapeutic Radiologic Physics and two are actively engaged in the ABR certification process. Seven of the program faculty hold adjunct faculty appointments in the LSU Department of Physics and Astronomy. There are currently 2.4 medical physics FTEs at MBPCC dedicated to academic endeavors (didactic graduate education, clinical training, and research). Dosimetry staffing includes nine medical dosimetry positions, eight of which are certified medical dosimetrists (CMDs). Physician staffing includes 11 radiation oncologists, all ABR-certified in Radiation Oncology. A part-time radiation biologist conducts research and assists in graduate education at LSU. Most staff members (academic and clinical) are also involved in didactic lectures, clinical training, and research within the Medical Physics graduate program.

Contact Information

Mary Bird Perkins Cancer Center Radiation Oncology Physics Residency Program
Mary Bird Perkins Cancer Center
4950 Essen Lane
Baton Rouge, LA 70808
Program Director: Jonas Fontenot, Ph.D.
Program Administrator:  Susan Hammond
Tel: (225) 215-1266 / Fax: (225) 215-1364
Email: MBPresidencyprogram@marybird.com

Willis-Knighton Medical Physics Residency Program
Willis-Knighton Cancer Center
2600 Kings Highway
Shreveport, LA 71103
Program Director: Hsinshun Terry Wu, Ph.D.
Tel: (318) 212-4639 / Fax: (318) 212-8305
Email: twu@wkhs.com

University of Mississippi Radiation Oncology Physics Residency Program
University of Mississippi Medical Center
350 West Woodrow Wilson Drive, Suite 1600
Jackson, MS 39213
Program Director: Chunli Yang (aka Claus), Ph.D.
Tel: (601) 815-7562 / Fax: (601) 815-6876
Email: cyang@umc.edu

AREAS OF RESEARCH

Our Medical Physics Program covers an array of research topics. Mary Bird Perkins Cancer Center and LSU are dedicated to teaching our students about the latest Medical Physics technologies and therapies, as well as furthering research in the areas below.

VOLUMETRIC MODULATED ARC THERAPY

Volumetric modulated arc therapy (VMAT) is a new radiation therapy technique that can decrease the time needed to delivery a radiation therapy treatment by 50% or more. VMAT delivery coordinates and optimizes the movement of the gantry, multi-leaf collimator and dose rate such that IMRT-quality dose distributions are delivered in a fraction of the time. Current VMAT research at Mary Bird Perkins Cancer Center focuses on determining proper clinical indications for use of VMAT and verifying that VMAT treatments are delivered as planned.

Investigators: Fontenot

IMAGE-GUIDED RADIATION THERAPY

Image-guided radiation therapy (IGRT) is used for highly-focused radiation therapy treatments to ensure that the tumor and surrounding healthy tissue are precisely positioned for treatment. IGRT radiotherapy is particularly useful for irradiation of brain and other small tumors of the head. We have developed a measurement technique with 0.3-mm accuracy to assess IGRT using the BrainLab Novalis ExacTrac System in the brain. Future studies will use this system to study other sites in the head and to study other modalities such as TomoTherapy MVCT and Elekta XVI.

Investigators: Fontenot, Hogstrom

ELECTRON CONFORMAL THERAPY

Electron beam therapy is an advantageous radiation therapy technique for treating tumors that are located at or near the surface of the skin. Segmented field ECT utilizes multiple abutted fields of differing energy. Dose uniformity at the borders of abutted fields was recently studied using energy-dependent source-to-collimator distances of the lead-alloy inserts and currently the potential of using an electron multileaf collimator (eMLC) to feather the borders is being investigated. Another issue under investigation is a forward planning algorithm for segmented field ECT. We also plan to investigate the improved utility of segmented field ECT for decreased energy spacing on radiotherapy linacs and how that compares with bolus ECT.

Investigators: Hogstrom, Carver

PROTON RADIATION THERAPY

Proton radiation therapy is a type of radiation therapy which uses a beam of protons to irradiate tumors. The chief advantage of proton therapy is the ability to more precisely localize the radiation dosage when compared with other types of radiation therapy. Proton therapy research at Mary Bird Perkins Cancer Center focuses on development of dose calculation algorithms that can better exploit the advantages of protons during treatment planning. We are also examining peripheral, or out-of-field, doses attributed to different types of proton radiation therapy treatments and contrasting them with other types of radiation therapy.

Investigators: Newhauser, Hogstrom, Fontenot, Zhang

ELECTRON BEAM DELIVERY SYSTEM

Electron beams are commonly used to treat superficial cancers. Our group has focused a great deal of effort into redesigning the Elekta Infinity linear accelerator’s electron delivery system.  Specifically, we are redesigning the dual flattening foil system and electron applicators in order to extend their utility and increase the robustness of their clinical use.  The dual flattening foil system acts to flatten and create a radially symmetrical beam for patient irradiation.  Electron applicators are used to collimate the electron beam close to the patient’s surface and protect the patient from any stray radiation created by the machine’s components.  To validate and improve our designs, a Monte Carlo model has been created of the Elekta Infinity in order to simulate the dosimetric properties of both the current and suggested component designs.

Investigators: Hogstrom, Carver

AUGER ELECTRON THERAPY

Auger electron therapy is a type of targeted therapy that aims to enhance radiation damage to the tumor while simultaneously avoiding damage to surrounding healthy tissue. The utility of using monochromatic x-rays (CAMD synchrotron light source) to initiate Auger electron therapy via iododeoxyuridine (IUdR) in cellular DNA is under investigation. A radiation therapy experimental beam line (FS= 3×3 cm2and E< 40 keV) has been configured and dosimetry methods established (Oves et al 2008). Current research is studying the increased biological effect of this therapy relative to conventional photon therapy on CHO cells as a function of energy and % IUdR. Future experiments will involve small animals and study the ability of using a free-electron laser in lieu of the synchrotron.

Investigators: Hogstrom, Matthews

SURVIVORSHIP AND SECONDARY EFFECTS IN RADIATION THERAPY

The secondary effects research at Mary Bird Perkins Cancer Center focuses on cancer prevention and cancer survivorship. Specifically, we seek to better understand the risks of treatment-related health problems faced by cancer survivors. The long term goal is to provide an enhanced based of evidence for making clinical decisions (e.g., selection of radiation treatment modality) and health care policy decisions (rational allocation of scarce health care resources). Our recent research has focused on children and young adults, e.g., with tumors of the central nervous system and Hodgkin Disease. We have also studied treatments for cancer of the prostate, liver, lung and other sites. Our research examines advanced radiotherapies, such as intensity modulated proton and photon therapies, as well as conventional photon therapy. This research is trans-disciplinary, including medical physics, software and nuclear engineering, high performance computing, statistics, cancer prevention and epidemiology and oncology.

Investigators: Newhauser, Zhang, Fontenot

LIST OF PUBLICATIONS

2015

W. Newhauser and R. Zhang, “The physics of proton therapy,” Phys. Med. Biol. (2015).

L. Wilson, D. Mirkovic and W. Newhauser, “A simple and fast physics-based analytical method to calculate therapeutic and stray doses from external beam, megavoltage x-ray therapy
,” Phys. Med. Biol. 60 4753-4775 (2015).

R. Zhang*, D. Mirkovic and W. Newhauser, “Visualization of risk of radiogenic second cancer in the organs and tissues of the human body,” Radiat Oncol 10: 107 (2015). http://www.ro-journal.com/content/10/1/107

2014

D. Alvarez, K. R. Hogstrom, K. L. Matthews II, K. Ham, T. D. Brown, and M. E. Varnes. “Impact of IUdR on rat glioma cell survival for 25-35 keV photon-activated Auger electron therapy,” Rad Res 182”607-17 (2014).

M. Sutton, J. D. Fontenot, K. Matthews, B. Parker, M. King, J. Gibbons, and K. Hogstrom, “Accuracy and precision of cone beam CT-guided intensity modulated radiation therapy,” Pract Radiat Oncol 4: e67-e73 (2014).

G. Nichols, J. D. Fontenot, J. P. Gibbons, and M. Sanders, “Evaluation of volumetric modulated arc therapy for postmastectomy treatment,” Radiat Oncol 9 1-8 (2014).

J. Fontenot, “Evaluation of a novel secondary check tool for intensity modulated radiation therapy treatment planning,” J App Clin Med Phys 15:4990-4997 (2014)

H. Wang and O. N. Vassiliev, “Microdosimetric characterization of radiation fields for modelling tissue response in radiotherapy,” at press in Int J Cancer Ther Oncol 2(1): 1-10 (2014).

H. Wang and O.N. Vassiliev, “Radial dose distributions from protons of therapeutic energies calculated with GEANT4-DNA,” Phys Med Biol 59: 3657- 68 (2014).

JP Gibbons, JA Antolak, DS Followill, MS Huq, EE Klein, KL Lam, JR Palta, DM Roback, and FM Khan, “Monitor unit calculations for external photons and electron beams: Report of the AAPM Therapy Physics Committee Task Group 71,” Med Phys 41 (2014).

J. D. Fontenot, H. Alkhatib, J. Garrett, A. Jensen, S. McCullough, A. Olch, B. Parker, and C. Yang, “AAPM medical physics practice guideline: commissioning and quality assurance of x-ray based image guided radiotherapy systems,” J App Clin Med Phys 15: 3-13 (2014)

BC Parker, J Duhon, CC Yang, HT Wu, KR Hogstrom, and JP Gibbons, “Medical Physics Residency Consortium: collaborative endeavors to meet the ABR 2014 certification requirements,” J App Clin Med Phys 15: 337-44 (2014).

WD Newhauser, T Jones, S Swerdloff, R Zhang, and WA Newhauser, “Anonymization of DICOM Electronic Medical Records for Radiation Therapy,” Comp Biol Med 53:134-40 (2014).

Y Akino, JP Gibbons, DW Neck, C Chu, and IJ Das, “Intra- and intervariability in beam data commissioning among water phantom scanning systems,” J App Clin Med Phys 15: 251-8 (2014).

Vassiliev, “A model of the radiation-induced bystander effect based on an analogy with ferromagnets. Application to modelling tissue response in a uniform field,” Physica A 416: 242-251 (2014).

JG Eley, WD Newhauser, R Luchtenborg, C Graeff, and C Bert, “4D Optimization of scanned ion beam tracking therapy for moving tumors” Phys Med Biol 59: 3431-52 (2014).

R. Zhang, R. Howell, P. Taddei, A. Giebeler, A. Mahajan, and W. Newhauser “A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation,” Radiother and Oncol 113:84-8 (2014).

R. Carver, K. R. Hogstrom, M. J. Price, J. Leblanc, and G. Pitcher, “Real time simulator for designing dual scattering foil systems,” J App Clin Med Phys 15: 4849-59 (2014).

2013

R. Zhang, R. M. Howell, A. Giebeler, P. J. Taddei, A. Mahajan, W. D. Newhauser. “Comparison of Risk of Radiogenic Second Cancer between Photon and Proton Craniospinal Irradiation for a Pediatric Medulloblastoma Patient.” Phys Med Biol 58(4): 807-23 (2013).

R. Zhang, J. D. Fontenot, D. Mirkovic, J. Hendricks, W. D. Newhauser. “Advantages of MCNPX-Based Lattice Tally over Mesh Tally in High-Speed Monte Carlo Dose Reconstruction for Proton Radiotherapy.” Nucl Tech 183: 1-6 (2013).

A. Giebeler, W. D. Newhauser, R. A. Amos, A. Mahajan, K. Homann, and R. M. Howell. “Standardized Treatment Planning Methodology for Passively Scattered Proton Craniospinal Irradiation.” Rad Onc 8: 32 (2013).

W. Newhauser, L. Rechner, D. Mirkovic, P. Yepes, N. Koch, J. D. Fontenot, and R. Zhang, “Benchmark measurements and simulations of dose perturbations due to metallic spheres in proton beams,” Radiat Meas 58 37-44 (2013).

R. Zhang, R. Howell, K. Homann, A. Giebeler, P. Taddei, A. Mahajan, and W. Newhauser, “Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy, “ Radiat Oncol 8: 184-193 (2013).

A. Perez-Andujar, W Newhauser, P Taddei, A Mahajan, and RM Howell, “The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation,” Phys Med Biol 58(10): 3107-3123 (2013).

P Taddei, W Jalbout, R Howell, N Khater, F Geara, K Homann, and W Newhauser, “Analytical model for out-of-field dose in photon craniospinal irradiation,” Phys Med Biol 58(21): 7463-7479 (2013).

A. Perez-Andujar, R Zhang, and W Newhauser, “Monte Carlo and analytical model predictions of leakage neutron exposures from passively scattered proton therapy,” Med Phys 40(12): 121714 (2013).

J. D. Fontenot and E. E. Klein, “Technical challenges in liver stereotactic body radiation therapy: reflecting on the progress,” (editorial) Int J Radiat Oncol Biol Phys 85 869-870 (2013).

Kavanaugh, K. Hogstrom, C. Chu, R. Carver, J.D. Fontenot, and G. Henkelmann, “Delivery confirmation of bolus electron conformal therapy combined with intensity modulated x-ray therapy,” Med Phys 40 0217241 (2013).

RL Carver, KH Hogstrom, C Chu, RS Fields, and CP Sprunger, “Accuracy of Pencil-Beam Redefinition Algorithm Dose Calculations in Patient-Like Cylindrical Phantoms for Bolus Electron Conformal Therapy”, Med Phys 40 071720 (2013).

J Silkwood, KL Matthews, and PM Shikhaliev. “Photon counting spectral breast CT: effect of adaptive filtration on CT number, noise, and contrast to noise ratio” Med Phys 40(5): 051905 (2013).

X Wang, JN Yang, X Li, R Tailor, O Vassiliev, P Brown, L Rhines, and E Change, “Effect of spine hardware on small spinal stereotactic radiosurgery dosimetry,” Phys Med Biol 58: 6733-47 (2013)

2012

Shikhaliev, P.M. “Dedicated phantom materials for spectral radiography and CT.” Physics in Medicine and Biology 57: 6, 2012. http://iopscience.iop.org/0031-9155/57/6/1575/

Shikhaliev, P.M. “Photon counting spectral CT: improved material decomposition with K-edge-filtered x-rays.” Physics in Medicine and Biology 57: 6, 2012. http://iopscience.iop.org/0031-9155/57/6/1595/

Newhauser, W.D., Scheurer, M.E., Faupal-Badger, J.M., Clague, J., Weitzel, J., Woods, K.V. “The Future Workforce in Cancer Prevention: Advancing Discovery, Research, and Technology.” Journal of Cancer Education Supplement 2, 2012.

Shikhaliev, P.M. “Dedicated phantom materials for spectral radiography and CT.” Physics in Medicine and Biology 57: 6, 2012.

Shikhaliev, P.M. “Photon counting spectral CT: improved material decomposition with K-edge-filtered x-rays.” Physics in Medicine and Biology 57: 6, 2012.

Howell, R.M., Giebeler, A., Koontz-Raisig, W., Mahajan, A., Etzel, C.J., D’Amelio Jr, A.M., Homann, K.L., Newhauser, W.D. “Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma.” Radiation Oncology 7:1, 2012.

Rechner, L.A., Howell, R.M., Zhang, R., Etzel, C., Lee, A.K., Newhauser, W.D. “Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.” Physics in Medicine and Biology 57:21, 2012.

Mancuso, G.M., Fontenot, J.D., Gibbons, J.P., Parker, B.C. “Comparison of action levels for patient-specific quality assurance of intensity modulated radiation therapy and volumetric modulated arc therapy treatments.” Medical Physics 39:7, 2012.

Fontenot, J.D. “Feasibility of a remote, automated daily delivery verification of volumetric-modulated arc therapy treatments using a commercial record and verify system.” Journal of Applied Clinical Medical Physics 13:2, 2012.

Rechner, L.A., Howell, R.M., Zhang, R., Newhauser, W.D. “Impact of margin size on the predicted risk of radiogenic second cancers following proton arc therapy for prostate cancer.” Physics in Medicine and Biology 57:23, 2012.

Vassiliev, O.N. “Formulation of the Multi-hit Model with a Non-Poisson Distribution of Hits.” International Journal of Radiation Oncology Biology Physics83:4, 2012.

Vassiliev, O.N., Kudchadker, R.J., Kuban, D.A., Frank, S.J., Choi, S., Nguyen, Q., Lee, A.K. “Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy.” Physica Medica 28:3, 2012.

Vassiliev, O.N. “Electron slowing-down spectra in water for electron and photon sources calculated with Geant4-DNA code.” Physics in Medicine and Biology 57:4, 2012.

Brown, T.A.D., Hogstrom, K.R., Alvarez, D., Matthews II, K.L., Ham, K., Dugas, J.P. “Dose-response curve of EBT, EBT2, and EBT3 radiochromic films to synchrotron-produced monochromatic x-ray beams.” Medical Physics 39:12, 2012.

Brown, T.A.D., Hogstrom, K.R., Alvarez, D., Matthews II, K.L., Ham, K. “Veridication of TG-61 does for synchrotron-produced monochromatic x-ray beams using fluence-normalized MCNP5 calculations.” Medical Physics 39:12, 2012.

Bao, Q., Hrycushko, B.A., Dugas, J.P., Hager, F.H., Solberg, T.D. “A Technique for Pediatric Total Skin Electron Irradiation.” Radiation Oncology 7:40, 2012.

Majdzadeh, N., Jain, S.K., Murphy, M.C., Dugas, J.P., Hager, F. Abdulrahman, R. “Total Skin Electron Beam Radiation in a Pediatric Patient with Leukemia Cutis, A case report.” Journal of Pediatric Hematology/Oncology 34:7, 2012.

2011

Howell, R. and Newhauser, W.D. “TH?B?BRA?01: Educational course therapy.” Medical Physics 38, 3849, 2011.

Taddei, P.J., Mirkovic, D., Howell, R.M., Zhang, R., Giebeler, A., Mahajan A., and Newhauser, W.D. “MO?G?BRC?01: Comparison of the risk of second malignant neoplasm in a developed country versus a developing country for a 13-year-old girl receiving craniospinal irradiation.” Medical Physics 38, 3736, 2011.

Giebeler, A., Howell, R., Zhang, R., Mahajan, A., and Newhauser, W.D. “SU?E?T?47: A Method to increase statistical power in micro?clinical trials for second cancers following advanced techniques for pediatric radiotherapy.” Medical Physics, 38, 3496, 2011.

Zhang, R., Howell, R., Giebeler, A., Taddei, P., Mahajan, A., and Newhauser, W.D.“SU?E?T?43: Calculation of the risks of second cancer and cardiac toxicities for a pediatric patient treated with photon and proton radiotherapies.” Medical Physics, 38, 3495, 2011.

Randeniya, S., Mirkovic, D., Kry, S., Titt, U., Newhauser, W.D., and Howell, R. “MO?G?BRC?02: Patient specific out?of?field dose calculation tool for 6MV and 18MV: Development and validation.” Medical Physics, 38, 3736, 2011.

Luo, D., Eley, J., Du, W., Shiu, A., Chang, E., Brown, P., and Newhauser, W.D. “SU?E?T?244: Should treatment time be included in assessing the quality of a gamma plan?” Medical Physics, 38, 3543, 2011.

Rechner, L., Howell, R., Zhang, R., and Newhauser, W.D., and Lee, A. “WE?G?BRA?03: Risk of second malignant neoplasms following VMAT and proton arc therapy for prostate cancer.” Medical Physics, 38, 3826, 2011.

Huang, J., Newhauser, W., Zhu, X., Lee, A., and Kudchadker, R. “TU?G?BRB?01: Investigation of dose perturbations and radiographic visibility of potential fiducials for proton radiation therapy of the prostate.” Medical Physics, 38, 3778, 2011.

Brown, T., Matthews, K., Ham, K., Alvarez, D., and Hogstrom, K. “SU-C-224-09: Energy and dose calibration of a synchrotron-produced monochromatic X-ray beam.” Medical Physics, 38, 3367, 2011.

Kavanaugh, J., Carver, R., Chu, C., Mancuso, G., and Hogstrom, K. “SU-E-T-400: Evaluation of a pencil beam algorithm and pencil beam redefinition algorithm for bolus electron conformal therapy.” Medical Physics, 38, 3580, 2011.

Carver, R., Hogstrom, K., and Chu, C. “SU-E-T-732: Accuracy of electron dose From pencil-beam redefinition algorithm in patient-like 2D phantoms.” Medical Physics, 38, 3659, 2011.

Carver, R., Hogstrom, K., Chu, C. “SU-E-T-750: Interfacing the pencil beam redefinition algorithm with a commercial treatment planning system.” Medical Physics, 38, 3663, 2011.

Kavanaugh, J., Chu, C., Perrin, D., and Hogstrom, K. “SU-E-T-807: Measured data set for validation of bolus electron conformal therapy.” Medical Physics, 38, 3676, 2011.

Mancuso, G., Fontenot, J., Parker, B., Neck, D., González, G., and Gibbons, J. “SU-E-T-415: Investigation of VMAT patient specific quality assurance action levels.” Medical Physics, 38, 3583, 2011.

Mathews, B. and Price, M. “SU-E-T-369: Comparison of Monte Carlo calculations around an intracavitary brachytherapy CT-MR compatible Fletcher applicator with radiochromic film.” Medical Physics, 38, 3572, 2011.

Mathews, B. and Price, M. “SU-E-T-379: Development of a Monte Carlo based correction strategy for a TG-43 based brachytherapy treatment planning system to account for applicator inhomogeneities.” Medical Physics, 38, 3575, 2011.

Sutton, M., Matthews, K., and Parker, B. “SU-E-T-293: Accuracy of Elekta – image guided radiation therapy.” Medical Physics, 38, 3555, 2011.

Parker, B., Hogstrom, K., Gibbons, J., Mitra, R., Duhon, J., Yang, C., and Wu, H. “A hub-and-spoke residency model for meeting the 2014 ABR mandate.”

Fontenot, J. and Gibbons, J. “SU-E-T-24: Remote, automated daily delivery verification of volumetric modulated arc therapy treatments. Using a commercial record and verify system.” Medical Physics, 38, 3490, 2011.

Roberts, M., Parker, B., Gibbons, J., Price, M., Sanders, M., and Sprunger, P. “SU-E-T-486: Comparison of TLD measured dose and MVCT reconstructed dose for post-mastectomy chest wall irradiation with TomoTherapy.”  Medical Physics, 38, 3600, 2011.

WD Newhauser, ME Scheurer, JM Faupel-Badger, J Clague, J Weitzel, and KV Woods.  The Future Workforce in Cancer Prevention: Advancing Discovery, Research, and Technology, J. Ca Education (accepted for publication).

Fontenot, J.D., King, M.L., Johnson, S.A., Wood, C.G., Price, M.J., and Low, K.K. “Single-arc volumetric

modulated arc therapy can provide dose distributions equivalent to fixed-beam IMRT for prostatic irradiation with seminal vesicle or lymph node involvement.” The British Journal of Radiology, June 2011. http://bjr.birjournals.org/content/early/2011/06/28/bjr.94843998.abstract(epub ahead of print).

Matney, J. E., Parker, B.C., Neck D.W., Henkelmann, G.C., and Rosen, I.I. “Target localization accuracy in a respiratory phantom using BrainLab ExacTrac and 4DCT imaging.” Journal of Applied Clinical Medical Physics 12: 301-309, 2011.

Moldavan, M., Fontenot, J.D., Gibbons, J.P., Lee, T.K., Rosen, I.I., Fields, R.S., and Hogstrom, K.R. “Investigation of pitch and jaw width to decrease delivery time of helical tomotherapy.” Medical Dosimetry 36(4): 397-403, 2011.

Vassiliev, O.N., Kudchadker, R.J., Swanson, D.A., Bruno, T.L., van Vulpen, M., Frank, S.J. “Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy.” Brachytherapy 10:5, 2011.

2010

Ashenafi, M., Boyd, R.A., Lee, T.K., Lo, K.K., Gibbons, J.P., Rosen, I.I., Fontenot, J.P., and Hogstrom, K.R. “Feasibility of postmastectomy treatment with helical TomoTherapy.” International Journal of Radiation Oncology Biology Physics 77:836-42, 2010.

Fontenot, J.D., Bloch, C., Followill, U., Titt, U., and Newhauser, W.D. “Estimate of the uncertainties in

the relative risk of secondary malignant neoplasms following proton therapy and intensity modulated

photon therapy.” Physics in Medicine and Biology 55:6987-6998, 2010.

Ito, S., Parker, B.C., Levine R., Sanders, M.E., Fontenot J., Gibbons, J.P., and Hogstrom, K.R. “Verification of calculated skin doses in post-mastectomy helical tomoTherapy.” International Journal of Radiation Oncology Biology Physics 81(2), 584-591, 2010.

Matney, J.E., Parker, B.C., Neck, D.W., Henkelmann, G.C., and Rosen, I.I. “Evaluation of a commercial flatbed document scanner and medical grade film scanner for radiochromic film dosimetry.” Journal of Applied Clinical Medical Physics 11(2): 198-208, 2010.

Price, M., Kry S., Eifel P., Salehpour M., and Mourtada, F. “Dose perturbation due to the polysulfone cap surrounding a Fletcher-Williamson colpostat.” Journal of Applied Clinical Medical Physics 11(1), 68-76, 2010.

Shikhaliev, P.M., Petrek P., Mathews II, K.L., Fritz, S.G., Bujenovic, L.S., and Xu, T. “Intravascular imaging with a storage phosphor detector.” Physics in Medicine and Biology 55: 2841-2861, 2010.

Shikhaliev, P.M. “The upper limits of the SNR in radiography and CT with polyenergetic X-rays.” Physics in Medicine and Biology 55: 5317-5139, 2010.

Carver, R., Cunningham, A., Frank, A., Hartigan, P., Cocker, R., Wilde, B., Foster, J., Rosen, P. “Laboratory Astrophysics and Non-ideal Equations of State: The Next Challenges for Astrophysical MHD Simulations.” High Energy Density Physics 6:4, 2010.

Kry, S.F., Vassiliev, O.N., Mohan, R. “Out-of-field photon dose following removal of the flattening filter from a medical accelerator.” Physics in Medicine and Biology 55:8, 2010.

Vassiliev, O.N., Wareing, T.A., McGhee, J., Failla, G., Salehpour, M.R., Mourtada, F. “Validation of a new grid-based Boltzmann equation solver for dose calculation in radiotherapy with photon beams.” Physics in Medicine and Biology 55:3, 2010.

2009

Fritz, S.G. and Shikhaliev, P.M. “CZT detectors used in different irradiation geometries: Simulations and experimental results.” Medical Physics 36(4): 1098-1108, 2009.

Fritz, S.G. and Shikhaliev, P.M. “Projection X-ray imaging with photon energy weighting: Experimental evaluation of a prototype detector.” Physics in Medicine and Biology 54: 4971- 4992, 2009.

Gerbi, B.J., Antolak, J.A., Followill, D.S., Herman, M.G., Higgins, P.D., Huq, M.S., Mihailidis, D.N., Yorke, E.D., Hogstrom, K.R., and Khan, F.M. “Recommendations for clinical electron beam dosimetry: Supplement to the recommendations of task group 25.” Medical Physics 36: 3239-3279, 2009.

Gibbons, J.P., Smith, K., Cheek, D., and Rosen, I.I. “Independent calculation of dose from a helical TomoTherapy unit.” Journal of Applied Clinical Medical Physics 10: 103-119, 2009.

Shikhaliev, P.M., Fritz, S.G., and Chapman, J.W. “Photon counting multi-energy XD-ray imaging: Effect of the characteristic X-rays on detector performance.” Medical Physics 36(11): 5107-5119, 2009.

Weinberg, R., Antolak, J.A., Starkschall, G., Kudchadker, R.J., White, R.A., and Hogstrom, K.R. “Influence of source parameters on large-field electron beam profiles calculated using Monte Carlo methods.” Physics in Medicine and Biology 54: 105-116, 2009.

Hartigan, P., Foster, J., Wilde, B., Coker, R., Rosen, P., Hansen, F., Blue, B., Williams, R., Carver, R., Frank, A. “Laboratory Experiments, Numerical Simulations, and Astronomical Observations of Deflected Supersonic Jets: Application to HH110.” The Astrophysics Journal 705, 2009.

Kry, S.F., Howell, R.M., Polf, J., Mohan, R., Vassiliev, O.N. “Treatment vault shielding for a flattening filter-free medical linear accelerator.” Physics in Medicine and Biology 54:5, 2009.

Vassiliev, O.N., Kry, S.F., Chang, J.Y., Balter, P.A., Titt, U., Mohan, R. “Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac.” Journal of Applied Clinical Medical Physics 10:1, 2009.

2008

Beardmore, A., Rosen, I.I., Cheek, D., Fields, R.S., and Hogstrom, K.R. “Evaluation of MVCT images with skin collimation for electron beam treatment planning.” Journal of Applied Clinical Medical Physics 9(3): 43-57, 2008.

Cheek, D., Gibbons, J.P., Rosen, I.I., and Hogstrom, K.R. “Accuracy of TomoTherapy treatments for superficial target volumes.” Medical Physics 35: 3565-73, 2008.

Das, I.J., Cheng, C.W., Watts, R.J, Ahnesjö, A., Gibbons, J., Li, X.A., Lowenstein, J., Mitra, R.K, Simon, W.E.,

Zhu, T.C., and TG-106 of the therapy physics committee of the AAPM. “Accelerator beam data commissioning equipment and procedures: Report of the TG-106 of the Therapy Physics Committee of the AAPM.” Medical Physics 35:4186-4215, 2008.

Dugas, J.P., Oves, S., Sajo, E., Matthews II, K.L., Ham, K., and Hogstrom, K.R. “Monochromatic beam characterization for Auger electron dosimetry and radiotherapy.” European Journal of Radiology 68S:
137-141, 2008.

Lee, T.K., Rosen, I.I, Gibbons, J.P., Fields, R.S., Hogstrom, K.R. “Helical TomoTherapy for parotid gland tumors.” International Journal of Radiation Oncology Biology Physics 70: 883-91, 2008.

Oves, S., Hogstrom K.R., Ham, K., Sajo, E., and Dugas, J.P. “Dosimetry intercomparison using a 35-keV x-ray synchrotron beam.” European Journal of Radiology 68S:121-125, 2008.

Shikhaliev, P.M. “Computed tomography with energy resolved detection: A feasibility study.” Physics in Medicine and Biology 53: 1475-1495, 2008.

Shikhaliev, P.M. “Energy resolved computed tomography: First experimental results.” Physics in Medicine and Biology 53: 5595-5813, 2008.

Smith, K., Gibbons, J.P., Gerbi, B.J., Hogstrom, K.R. “Measurement of superficial dose from a static TomoTherapy beam.” Medical Physics 35: 769-774, 2008.

Vinci, J., Hogstrom, K.R., and Neck, D. “Accuracy of cranial coplanar beam therapy with BrainLab ExacTrac image guidance.” Medical Physics 35: 3809-19, 2008.

Wang, W-H., Matthews II, K.L., and Teague, R.E.. “Dose rates of a cobalt-60 pool irradiator measured with Fricke dosimeters.” Health Physics 94 (Supplement 2): S44-S50, 2008.

Vassiliev, O.N., Wareing, T.A., Davis, I.M., McGhee, J., Barnett, D., Horton, J.L., Gifford, K., Failla, G., Titt, U., Mourtada, F. “Feasibility of a multigroup deterministic solution method for three-dimensional radiotherapy dose calculations.” International Journal of Radiation Oncology Biology Physics 72:1, 2008.

Kry, S.F., Howell, R.M., Titt, U., Salehpour, M., Mohan, R., Vassiliev, O.N. “Energy spectra, sources, and shielding considerations for neutrons generated by a flattening filter-free Clinac.” Medical Physics 35:5, 2008.

Titt, U., Zheng, Y., Vassiliev, O.N., Newhauser, W.D. “Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.” Physics in Medicine and Biology53:2, 2008.

2007

Richert, J.D., Hogstrom, K.R., Fields R. S., Matthews II, K.L., and Boyd, R.A. “Improvement of field matching in segmented-field electron conformal therapy using a variable-SCD applicator.” Physics in Medicine and Biology 52: 2459-2481, 2007.

Kry, S.F., Titt, U., Followill, D., Pönisch, F., Vassiliev, O.N., White, R.A., Stovall, M., Salehpour, M. “A Monte Carlo model for out-of-field dose calculation from high-energy photon therapy.” Medical Physics 34:9, 2007.

Vassiliev, O.N., Kry, S.F., Kuban, D.A., Salehpour, M., Mohan, R., Titt, U. “Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a varian clinac operated without a flattening filter.” International Journal of Radiation Oncology Biology Physics 68:5, 2007.

Kry, S.F., Titt, U., Pönisch, F., Vassiliev, O.N., Salehpour, M., Gillin, M., Mohan, R. “Reduced neutron production through use of a flattening-filter-free accelerator.” International Journal of Radiation Oncology Biology Physics 68:4, 2007.

Vassiliev, O.N., Titt, U., Kry, S.F., Mohan, R., Gillin, M.T. “Radiation safety survey on a flattening filter-free medical accelerator.” Radiation Protection Dosimetry 124:2, 2007.

Cho, S.H., Vassiliev, O.N., Horton, J.L. “Comparison between an event-by-event Monte Carlo code, NOREC, and ETRAN for electron scaled point kernels between 20 keV and 1 MeV.” Radiation and Environment Biophysics 46:1, 2007.

2006

Hogstrom, K.R. “Education and training of medical physicists in America.” Japanese Journal of

Medical Physics 26 (suppl. No. 1): 31-43, 2006.

Hogstrom K.R. and Almond, P.R. “Review of electron beam therapy physics.” Physics in Medicine and

Biology 55: R455-489, 2006.

Matthews II, K.L., Aarsvold, J.N., Mintzer, R.A., Chen, C.T., and Lee, R.C. “Tc-99m Pyrophosphate imaging of poloxamer-treated electroporated skeletal muscle in an in vivo rat model.” Burns 32:755-764, 2006.

Wang, W-H., J.D. McGlothlin, D.J. Smith, and Matthews II, K.L. “Evaluation of a radiation survey training video developed from a real-time video radiation detection system.” Health Physics 90 (Supplement 1): S33-S39, 2006.

Wang, W-H., Matthews II, K.L., and Scott, L.M. “Lessons learned in responding to and recovering from a fire incident.” Health Physics 91 (Supplement 2): S78-S82, 2006.

Wang, W-H. and Matthews II, K.L. “Simulating gaseous iodine-131 distribution in a silver zeolite cartridge using sodium iodide solution.” Health Physics 90 (Supplement 2): S73-S79, 2006.

Kry, S.F., Titt, U., Pönisch, F., Followill, D., Vassiliev, O.N., White, R.A., Mohan, R., Salehpour, M. “A Monte Carlo model for calculating out-of-field dose from a Varian 6 MV beam.” Medical Physics 33:11, 2006.

Jang, S.Y., Liu, H.H., Wang, X., Vassiliev, O.N., Siebers, J.V., Dong, L., Mohan, R. “Dosimetric verification for intensity-modulated radiotherapy of thoracic cancers using experimental and Monte Carlo approaches.” International Journal of Radiation Oncology Biology Physics 66:3, 2006.

Titt, U., Vassiliev, O.N., Pönisch, F., Kry, S.F., Mohan, R. “Monte Carlo study of backscatter in a flattening filter free clinical accelerator.” Medical Physics 33:9, 2006.

Pönisch, F., Titt, U., Vassiliev, O.N., Kry, S.F., Mohan, R.” Properties of unflattened photon beams shaped by a multileaf collimator.” Medical Physics 33:6, 2006.

Titt, U., Vassiliev, O.N., Pönisch, F., Dong, L., Liu, H., Mohan, R. “A flattening filter free photon treatment concept evaluation with Monte Carlo.” Medical Physics 33:6, 2006.

Vassiliev, O.N., Titt, U., Pönisch, F., Kry, S., Mohan, R., Gillin, M.T. “Dosimetric properties of photon beams from a flattening filter free clinical accelerator.” Physics in Medicine and Biology 51:7, 2006.

Vassiliev, O.N., Titt, U., Kry, S.F., Pönisch, F., Gillin, M.T., Mohan, R. “Monte Carlo study of photon fields from a flattening filter-free clinical accelerator.” Medical Physics 33:4, 2006.

Jang, S.Y., Vassiliev, O.N., Liu, H.H., Mohan, R., Siebers, J.V. “Development and commissioning of a multileaf collimator model in Monte Carlo dose calculations for intensity-modulated radiation therapy.” Medical Physics 33:3, 2006.

Pönisch, F., Titt, U., Kry, S.F., Vassiliev, O.N., Mohan, R. “MCNPX simulation of a multileaf collimator.” Medical Physics 33:2, 2006.

Matsen, M.W., Griffiths, G.H., Wickham, R.A., Vassiliev, O.N. “Monte Carlo phase diagram for diblock copolymer melts.” Journal of Chemical Physics 124:2, 2006.

© Copyright 2017 Mary Bird Perkins Cancer Center. All rights reserved.